This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1980 Mar;41(3):481-4.

doi: 10.1038/bjc.1980.74.

A serum factor with potential as a tumour marker in malignant lymphoma

R H Begent, D F Tucker, J Keen

PMID: 7387837
PMCID: PMC2010245
DOI: 10.1038/bjc.1980.74

Free PMC article

A serum factor with potential as a tumour marker in malignant lymphoma

R H Begent et al. Br J Cancer. 1980 Mar.

Free PMC article

. 1980 Mar;41(3):481-4.

doi: 10.1038/bjc.1980.74.

Authors

R H Begent, D F Tucker, J Keen

PMID: 7387837
PMCID: PMC2010245
DOI: 10.1038/bjc.1980.74

No abstract available

PubMed Disclaimer

Similar articles

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, Renard N, Neidhardt-Berard EM, Coiffier B. Warzocha K, et al. J Clin Oncol. 1997 Feb;15(2):499-508. doi: 10.1200/JCO.1997.15.2.499. J Clin Oncol. 1997. PMID: 9053471
Ki-1 positive meningeal lymphoma in a patient with a history of Hodgkin lymphoma.
Serena M, Tonetto G, Belli P. Serena M, et al. Ital J Neurol Sci. 1991 Feb;12(1):93-7. doi: 10.1007/BF02337620. Ital J Neurol Sci. 1991. PMID: 1849505
Increased immunoglobulin E and interferon-gamma in patients with malignant lymphoma.
Melichar B, Krejsek J, Drahosova M, Jebavy L, Siroky O, Blaha M, Maly J. Melichar B, et al. Acta Haematol. 1995;94(3):167-8. doi: 10.1159/000204003. Acta Haematol. 1995. PMID: 7502637 No abstract available.
Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas.
Herberman RB, McCoy JL, Levine PH. Herberman RB, et al. Cancer Res. 1974 May;34(5):1222-7. Cancer Res. 1974. PMID: 4366992 Review. No abstract available.
[Malignant lymphoma--from the view of the clinician].
Rák K. Rák K. Orv Hetil. 1988 Dec 18;129(51):2723-7. Orv Hetil. 1988. PMID: 3064022 Review. Hungarian. No abstract available.

See all similar articles

Cited by

Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
Kilgallon W, Amlot PL, Williams BD. Kilgallon W, et al. Clin Exp Immunol. 1983 Aug;53(2):308-18. Clin Exp Immunol. 1983. PMID: 6411401 Free PMC article.
Identification of PEG-precipitable serum factor associated with malignant lymphoma as C-reactive protein.
Walker LC, Tucker DF, Begent RH. Walker LC, et al. Br J Cancer. 1983 Jan;47(1):161-4. doi: 10.1038/bjc.1983.20. Br J Cancer. 1983. PMID: 6821631 Free PMC article. No abstract available.
Circulating immune complexes of Hodgkin's disease contain an antigen that is present in Hodgkin and Reed-Sternberg cells.
Bepler G, Zhen QY, Havemann K. Bepler G, et al. J Cancer Res Clin Oncol. 1985;110(1):56-64. doi: 10.1007/BF00402503. J Cancer Res Clin Oncol. 1985. PMID: 2410427 Free PMC article.

References

1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
1. J Immunol. 1973 Oct;111(4):1219-27 - PubMed
1. J Mol Biol. 1973 Sep 15;79(2):237-48 - PubMed
1. J Immunol Methods. 1977;16(2):165-83 - PubMed
1. J Clin Invest. 1978 Jun;61(6):1570-81 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information